apolipoprotein E-derived peptides (Ai2)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameapolipoprotein E-derived peptides (Ai2)
Drug Alias NameapoEdpL-W
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVirus DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAi2 Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAi2 Ltd
Active IndicationsN/A
Inactive IndicationsVirus DiseasesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A